News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
350,690 Results
Type
Article (21393)
Company Profile (145)
Press Release (329138)
Multimedia
Podcasts (112)
Webinars (17)
Section
Business (106858)
Career Advice (899)
Deals (18883)
Drug Delivery (110)
Drug Development (52175)
Employer Resources (81)
FDA (7932)
Job Trends (7890)
News (189137)
Policy (17588)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (783)
Accelerated approval (19)
Adcomms (23)
Allergies (83)
Alliances (28254)
ALS (93)
Alzheimer's disease (821)
Antibody-drug conjugate (ADC) (209)
Approvals (8112)
Artificial intelligence (282)
Autoimmune disease (81)
Automation (15)
Bankruptcy (182)
Best Places to Work (5617)
BIOSECURE Act (14)
Biosimilars (170)
Biotechnology (64)
Bladder cancer (78)
Brain cancer (35)
Breast cancer (271)
Cancer (2454)
Cardiovascular disease (239)
Career advice (748)
Career pathing (24)
CAR-T (112)
CDC (14)
Cell therapy (303)
Cervical cancer (11)
Clinical research (45685)
Collaboration (1026)
Company closure (1)
Compensation (374)
Complete response letters (52)
COVID-19 (1187)
CRISPR (50)
C-suite (539)
Cystic fibrosis (88)
Data (3405)
Decentralized trials (2)
Denatured (27)
Depression (83)
Diabetes (252)
Diagnostics (1899)
Digital health (15)
Diversity (9)
Diversity, equity & inclusion (23)
Drug discovery (171)
Drug pricing (200)
Drug shortages (33)
Duchenne muscular dystrophy (137)
Earnings (41313)
Editorial (46)
Employer branding (10)
Employer resources (79)
Events (52265)
Executive appointments (620)
FDA (9533)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (3)
Frontotemporal dementia (5)
Funding (670)
Gene editing (91)
Generative AI (31)
Gene therapy (271)
GLP-1 (824)
Government (2035)
Grass and pollen (4)
Guidances (205)
Healthcare (6143)
HIV (28)
Huntington's disease (24)
IgA nephropathy (60)
Immunology and inflammation (186)
Immuno-oncology (39)
Indications (69)
Infectious disease (1320)
Inflammatory bowel disease (121)
Inflation Reduction Act (12)
Influenza (46)
Intellectual property (139)
Interviews (119)
IPO (7577)
IRA (53)
Job creations (2445)
Job search strategy (659)
JPM (52)
Kidney cancer (10)
Labor market (61)
Layoffs (346)
Leadership (27)
Legal (4163)
Liver cancer (39)
Longevity (8)
Lung cancer (360)
Lymphoma (219)
Machine learning (21)
Management (31)
Manufacturing (533)
MASH (104)
Medical device (2078)
Medtech (2086)
Mergers & acquisitions (11842)
Metabolic disorders (889)
Multiple sclerosis (105)
NASH (20)
Neurodegenerative disease (165)
Neuropsychiatric disorders (71)
Neuroscience (1556)
Neurotech (1)
NextGen: Class of 2026 (2413)
Non-profit (928)
Now hiring (45)
Obesity (518)
Opinion (232)
Ovarian cancer (71)
Pain (147)
Pancreatic cancer (102)
Parkinson's disease (155)
Partnered (18)
Patents (288)
Patient recruitment (252)
Peanut (19)
People (34727)
Pharmaceutical (76)
Pharmacy benefit managers (33)
Phase 1 (14496)
Phase 2 (19350)
Phase 3 (15352)
Pipeline (2951)
Policy (235)
Postmarket research (1622)
Preclinical (5198)
Press Release (29)
Prostate cancer (133)
Psychedelics (27)
Radiopharmaceuticals (181)
Rare diseases (536)
Real estate (3212)
Recruiting (33)
Regulatory (13875)
Reports (25)
Research institute (878)
Resumes & cover letters (141)
Rett syndrome (6)
RNA editing (12)
RSV (43)
Schizophrenia (118)
Series A (119)
Series B (85)
Service/supplier (7)
Sickle cell disease (66)
Special edition (21)
Spinal muscular atrophy (119)
Sponsored (18)
Startups (2068)
State (2)
Stomach cancer (12)
Supply chain (77)
Tariffs (94)
The Weekly (83)
Vaccines (412)
Venture capital (68)
Weight loss (377)
Women's health (40)
Worklife (9)
Date
Last 7 days (304)
Last 30 days (1060)
Last 365 days (15637)
2026 (1502)
2025 (15874)
2024 (18147)
2023 (20292)
2022 (26576)
2021 (27323)
2020 (25419)
2019 (20351)
2018 (15769)
2017 (17438)
2016 (16361)
2015 (19010)
2014 (14903)
2013 (12610)
2012 (13533)
2011 (13848)
2010 (12769)
Location
Africa (416)
Alabama (43)
Alaska (1)
Arizona (93)
Arkansas (8)
Asia (26081)
Australia (3411)
California (4983)
Canada (1863)
China (751)
Colorado (196)
Connecticut (197)
Delaware (181)
Europe (53986)
Florida (879)
Georgia (98)
Hawaii (2)
Idaho (21)
Illinois (472)
India (51)
Indiana (293)
Iowa (5)
Japan (323)
Kansas (83)
Kentucky (29)
Louisiana (7)
Maine (5)
Maryland (599)
Massachusetts (3935)
Michigan (68)
Minnesota (241)
Mississippi (3)
Missouri (43)
Montana (12)
Nebraska (14)
Nevada (36)
New Hampshire (10)
New Jersey (1895)
New Mexico (21)
New York (1377)
North Carolina (795)
North Dakota (2)
Northern California (2290)
Ohio (132)
Oklahoma (9)
Oregon (23)
Pennsylvania (1089)
Puerto Rico (19)
Rhode Island (30)
South America (621)
South Carolina (11)
Southern California (2147)
Tennessee (64)
Texas (663)
United States (18710)
Utah (97)
Virginia (183)
Washington D.C. (60)
Washington State (416)
West Virginia (1)
Wisconsin (49)
Wyoming (1)
350,690 Results for "innate pharma".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Innate Pharma Releases Its 2026 Financial Calendar
December 11, 2025
·
4 min read
Press Releases
Innate Pharma to Present at Jefferies Global Healthcare Conference 2025
November 17, 2025
·
4 min read
Press Releases
Innate Pharma Reports Third Quarter 2025 Business Update and Financial Results
November 13, 2025
·
10 min read
Press Releases
Innate Pharma Announces Conference Call and Webcast for Third Quarter 2025 Results and Business Updates
November 5, 2025
·
4 min read
Press Releases
Innate Pharma to Host Analyst and Investor Event on Lacutamab on October 28, 2025
October 14, 2025
·
8 min read
Press Releases
Innate Pharma Announces FDA Clearance to Proceed With TELLOMAK 3, a Confirmatory Phase 3 Trial of Lacutamab in CTCL
November 10, 2025
·
7 min read
Press Releases
Innate Pharma Reports First Half 2025 Business Update and Financial Results
September 17, 2025
·
19 min read
Press Releases
Innate Pharma Announces Its Participation in the 25th Edition of the European Midcap Event
September 15, 2025
·
4 min read
Press Releases
Innate Pharma Announces Conference Call and Webcast for First Half 2025 Financial Results and Business Update
September 10, 2025
·
4 min read
Press Releases
Innate Pharma Announces Its Participation in the BTIG Virtual Biotechnology Conference
July 29, 2025
·
4 min read
1 of 35,069
Next
